An Analysis of JADE2 in Non-Small Cell Lung Cancer (NSCLC)

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The JADE family, including JADE2, has known roles in cell regulation but is understudied in cancer.
• Understanding JADE2's role in non-small cell lung cancer (NSCLC) is crucial for potential therapeutic strategies.

Purpose of the Study:

• To investigate JADE2 expression (mRNA and protein) in NSCLC.
• To correlate JADE2 expression with patient survival and clinical data.
• To identify potential therapeutic targets related to JADE2.

Main Methods:

• Analysis of JADE2 mRNA and protein in surgically resected NSCLC tissues.
• Bioinformatic analyses of public online datasets.
• Correlation studies between JADE2 expression, survival, gene mutations, tumor mutational burden, and immune cell infiltration.

Main Results:

• JADE2 expression is significantly altered in NSCLC.
• Higher JADE2 expression is associated with improved 5-year overall survival.
• Identified links between JADE2 mRNA levels and gene mutations, tumor mutational burden, and immune cell infiltration.
• Discovered potential JADE2-targeting drugs.

Conclusions:

• JADE2 is a potential prognostic biomarker in NSCLC.
• Altered JADE2 expression impacts patient survival and tumor characteristics.
• JADE2 may offer clinical utility for NSCLC diagnosis, prognosis, and therapeutic stratification.